GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (LSE:INDV) » Definitions » EV-to-Revenue

Indivior (LSE:INDV) EV-to-Revenue : 2.12 (As of May. 02, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Indivior EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Indivior's enterprise value is £1,892.5 Mil. Indivior's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was £892.5 Mil. Therefore, Indivior's EV-to-Revenue for today is 2.12.

The historical rank and industry rank for Indivior's EV-to-Revenue or its related term are showing as below:

LSE:INDV' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.53   Med: 2.2   Max: 4.16
Current: 2.12

During the past 13 years, the highest EV-to-Revenue of Indivior was 4.16. The lowest was -0.53. And the median was 2.20.

LSE:INDV's EV-to-Revenue is ranked better than
54.25% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.36 vs LSE:INDV: 2.12

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-02), Indivior's stock price is £14.28. Indivior's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was £6.32. Therefore, Indivior's PS Ratio for today is 2.26.


Indivior EV-to-Revenue Historical Data

The historical data trend for Indivior's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior EV-to-Revenue Chart

Indivior Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.50 0.77 2.00 2.73 1.76

Indivior Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.97 2.64 2.48 1.76 2.53

Competitive Comparison of Indivior's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Indivior's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indivior's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indivior's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Indivior's EV-to-Revenue falls into.



Indivior EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Indivior's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1892.452/892.538
=2.12

Indivior's current Enterprise Value is £1,892.5 Mil.
Indivior's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was £892.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indivior  (LSE:INDV) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Indivior's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=14.28/6.323
=2.26

Indivior's share price for today is £14.28.
Indivior's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was £6.32.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indivior EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Indivior's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Indivior (LSE:INDV) Business Description

Traded in Other Exchanges
Address
234 Bath Road, Slough, Berkshire, GBR, SL1 4EE
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.